Eruptive milia during isotretinoin therapy.
Citation: Pediatric Dermatology. 34(6):728-729, 2017 Nov.PMID: 28940619Institution: MedStar Washington Hospital CenterDepartment: Dermatology | Medicine/Internal MedicineForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Acne Vulgaris/dt [Drug Therapy] | *Dermatologic Agents/ae [Adverse Effects] | *Exanthema/ci [Chemically Induced] | *Isotretinoin/ae [Adverse Effects] | Adolescent | Dermatologic Agents/tu [Therapeutic Use] | Humans | Isotretinoin/tu [Therapeutic Use] | MaleYear: 2017ISSN:- 0736-8046
- Cheng, Kyle:
- http://orcid.org/0000-0003-1237-1987
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 28940619 | Available | 28940619 |
Isotretinoin (13-cis-retinoic acid) is a synthetic vitamin A derivative that is effective in the treatment of recalcitrant, nodulocystic acne. To our knowledge, there are no reports in the medical literature of milia as a side effect of isotretinoin. We report a case of eruptive facial milia in the setting of isotretinoin treatment for acne. Copyright (c) 2017 Wiley Periodicals, Inc.
English